Reeju Amatya

454 citations
16 papers · 347 indexed · h-index 10
Topics
Nanoplatforms for cancer theranostics (7 papers)Nanoparticle-Based Drug Delivery (4 papers)Gold and Silver Nanoparticles Synthesis and Applications (4 papers)
Partner nations
South Korea

In The Last Decade

Reeju Amatya

15 papers receiving 344 citations

Peers

Reeju Amatya
Comparison fields: 5 of 79
  • Biomedical Engineering 183
  • Biomaterials 123
  • Materials Chemistry 87
  • Molecular Biology 65
  • Electronic, Optical and Magnetic Materials 42
Replace Syed Baseeruddin Alvi with:
Syed Baseeruddin Alvi India
Haiyang Hu China
Ruimin Long China
Menglu Zhu China
Xia-Rong Wang China
Noor Alrushaid Saudi Arabia
Jiafeng Zou China
Mohamed A. Safwat Egypt
So Hee Nam South Korea
Henrique Luís Piva Brazil
Reeju Amatya relative to Syed Baseeruddin Alvi India Syed Baseeruddin Alvi's profile →
Citations per field
00.5×1.5×
Syed Baseeruddin Alvi · 1×
Citations per year

Countries citing papers authored by Reeju Amatya

Since Specialization
Citations

This map shows the geographic impact of Reeju Amatya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reeju Amatya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reeju Amatya more than expected).

Fields of papers citing papers by Reeju Amatya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reeju Amatya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reeju Amatya. The network helps show where Reeju Amatya may publish in the future.

Co-authorship network of co-authors of Reeju Amatya

This figure shows the co-authorship network connecting the top 25 collaborators of Reeju Amatya. A scholar is included among the top collaborators of Reeju Amatya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reeju Amatya. Reeju Amatya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 0
2 1
3 3
4 23
5 9
6 8
7 23
8 3
9 29
10 48
11 34
12 85
13 9
14 14
15 11
16 47

About Reeju Amatya

Reeju Amatya is a scholar working on Biomaterials, Dermatology and Electronic, Optical and Magnetic Materials, having authored 16 papers that have together received 347 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (7 papers), Nanoparticle-Based Drug Delivery (4 papers) and Gold and Silver Nanoparticles Synthesis and Applications (4 papers). The work is most often cited by research in Biomaterials (123 citations), Drug Discovery (1 citation) and Pharmaceutical Science (35 citations). Reeju Amatya has collaborated with scholars based in South Korea. Frequent co-authors include Meong Cheol Shin, Kyoung Ah Min, Taehoon Park, Heesun Cheong, Cheol Moon, Dasom Kim, Doyeon Kim, Jae Wook Yang, Jihyeong Lee and Dong-Hee Lee. Their work appears in journals such as Biomaterials, Journal of Controlled Release and Pharmaceutical Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026